Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous squamous cell carcinoma (cSCC), the most common type of metastatic skin cancer.

A drug already approved by the FDA to treat menopause symptoms may also help prevent invasive breast cancer, according to new ...

Discover 12 scientifically-backed breast cancer fighting foods. Learn which nutrients protect cells, reduce inflammation, and ...

Ongoing research is focusing on combining cryoablation with immunotherapy to trigger stronger immune responses and redefine ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous ...

ATLANTA, Ga. (WRDW/WAGT) - Colorectal cancer is the second-deadliest form of cancer in Georgia, with an estimated 4,940 new ...

AstraZeneca wins CHMP nod for Imfinzi combo in muscle-invasive bladder cancer, based on data from the phase III NIAGARA study ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous ...

Lymphovascular invasion is a pathologic feature commonly associated with aggressive renal cell carcinoma (RCC) and worse prognosis.

GE HealthCare (Nasdaq: GEHC) today announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for ...

Anal cancer is relatively uncommon, accounting for approximately 2.5% of all gastrointestinal cancers. Nonetheless, its ...